Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells

Risk factors for progression of age‐related macular degeneration

(2020) Thomas J Heesterbeek et al.   OPHTHALMIC AND PHYSIOLOGICAL OPTICS

Is generation of C3(H2O) necessary for activation of the alternative pathway in real life?

(2019) Kristina N. Ekdahl et al.   MOLECULAR IMMUNOLOGY

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia

(2018) Kanmin Xue et al.   NATURE MEDICINE

The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment

(2017) Maartje J. Geerlings et al.   MOLECULAR IMMUNOLOGY

Properdin binding to complement activating surfaces depends on initial C3b deposition

(2017) Morten Harboe et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The properdin pathway: an “alternative activation pathway” or a “critical amplification loop” for C3 and C5 activation?

(2017) Richard A. Harrison   Seminars in Immunopathology

Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina

(2017) Maria I. Patrício et al.   Molecular Therapy-Nucleic Acids

Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration

(2016) Judith Lechner et al.   Immunity & Ageing

Further studies of the down-regulation by Factor I of the C3b feedback cycle using endotoxin as a soluble activator and red cells as a source of CR1 on sera of different complotype

(2015) P. J. Lachmann et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants

(2015) Lars G Fritsche et al.   NATURE GENETICS

A critical analysis of codon optimization in human therapeutics

(2014) Vincent P. Mauro et al.   TRENDS IN MOLECULAR MEDICINE

Oxidative Stress Sensitizes Retinal Pigmented Epithelial (RPE) Cells to Complement-mediated Injury in a Natural Antibody-, Lectin Pathway-, and Phospholipid Epitope-dependent Manner

(2013) Kusumam Joseph et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

(2011) Peter A LeWitt et al.   LANCET NEUROLOGY

Structural basis for complement factor I control and its disease-associated sequence polymorphisms

(2011) P. Roversi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Complement: a key system for immune surveillance and homeostasis

(2010) Daniel Ricklin et al.   NATURE IMMUNOLOGY

The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification

(2009) Morten Harboe et al.   MOLECULAR IMMUNOLOGY

Oxidative damage–induced inflammation initiates age-related macular degeneration

(2008) Joe G Hollyfield et al.   NATURE MEDICINE

Systemic Complement Activation in Age-Related Macular Degeneration

(2008) Hendrik P. N. Scholl et al.   PLoS One